Archbold Pulmonology Achieves Milestone with 500th Robotic Biopsy

Archbold Pulmonology has reached a significant milestone by completing its 500th robotic bronchoscopic biopsy using the state-of-the-art Ion robotic bronchoscopy system. This achievement, celebrated on February 11, 2026, highlights the institution’s commitment to advanced diagnostic techniques aimed at improving patient care in Southwest Georgia.

Cutting-Edge Technology Enhances Patient Care

The Ion robotic bronchoscopy system allows pulmonologists to access difficult-to-reach lung nodules with remarkable precision. The team at Archbold, consisting of Dr. Ronald S. Batin, Dr. Christian J. Trujillo, and Dr. Luis Wulff, expressed their pride in achieving this milestone, which underscores the hospital’s ongoing investment in technology that supports earlier detection and treatment of lung conditions.

Dr. Batin noted, “The Ion system has been transformational for our practice and for this community. It allows us to access all 18 segments of the lungs to obtain tissue safely and accurately.” The technology not only facilitates accurate diagnostics but also aids in initiating timely treatment for patients diagnosed with cancerous nodules.

The Ion system features an ultra-thin, flexible catheter that enhances stability, allowing healthcare providers to navigate deep into the lungs with improved accuracy compared to traditional methods. This advancement represents a notable progression in the field of pulmonary medicine.

Addressing Patient Concerns Through Comprehensive Care

Lung nodules can arise from various conditions, including cancer, infections, and autoimmune diseases. Obtaining a precise biopsy is critical for determining the underlying cause and deciding on the best treatment approach.

Dr. Trujillo emphasized the emotional toll that uncertainty surrounding lung nodules can take on patients, stating, “Being able to provide timely answers and a clear path forward is one of the most meaningful aspects of what we do.” This commitment to patient care extends beyond diagnosis, with Archbold’s Lung Navigator, Montana Harstad, RN, closely coordinating resources for patients throughout their treatment journey.

Dr. Wulff added, “Completing our 500th robotic biopsy is a proud moment for our team. It represents not just a number, but hundreds of patients who were able to receive advanced diagnostic care close to home.” Archbold Pulmonology continues to strive for excellence by delivering cutting-edge technology and maintaining the highest standards of pulmonary care.

For more information about the Ion robotic biopsy system and the comprehensive services offered by Archbold Pulmonology, visit www.archbold.org/pulmonology.